Silence Therapeutics

Forecast & Rating7 analysts currently cover Silence Therapeutics, with about 85.7% giving a positive rating — meaning they expect the stock to rise. The average price target is $33.00, about 164.8% upside from the current price of $12.46. Price targets range from $10.00 to $75.00 — a wide spread, showing clear disagreement over just how much Silence Therapeutics can rise. Historically, about 9.8% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Silence Therapeutics closely still see room for the stock to rise. Data as of Sep 14, 2026; for reference only and not investment advice.